Covid ELISA Test for the Detection of IgG Antibodies - India CDSCO Medical Device Registration
Covid ELISA Test for the Detection of IgG Antibodies is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000083_3577e3a8042d3eeac49c224946ce5bd0_461554fcc50a35c781bf5c73eca2894c. This device is marketed under the brand name Q-Line. The license holder is POCT Services Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO -North Zone, Ghaziabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
Brand Name
Q-Line
License Holder
POCT Services Private LimitedDevice Class
Approving Authority
CDSCO -North Zone, Ghaziabad
Product Information
Q-lisa- Covid is an in-vitro qualitative enzyme immunoassay for the detection of IgG class of antibodies to SARS-CoV-2 in human serum or plasma. IgG antibodies to SARS-CoV-2 are generally detectable in blood several days after initial infection, although the duration of time antibodies are present post-infection is not well characterized. Individuals may have detectable virus present for several weeks following seroconversion
ฮฒ-hCG pregnancy test
Brand: Q-Line
KUTE WELLNESS INC
Dengue Antigen NS1
Brand: Q-Line
POCT Services Private Limited
Dengue Combo
Brand: Q-Line
POCT Services Private Limited
Malaria Antigen
Brand: Q-Line
POCT Services Private Limited
D-Dimer
Brand: Q-Line
POCT Services Private Limited
Viral Transport Kit
Brand: Q-Line
Shriram Institute For Industrial Research